Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cadmium ion (Cd²⁺) is the divalent cation form of cadmium, a highly toxic heavy metal. It has no known physiological function and exerts its toxicity through various mechanisms, including disruption of calcium homeostasis, enzyme inhibition, induction of oxidative stress, and mitochondrial dysfunction. Exposure to cadmium ions can lead to a range of adverse health effects, including kidney disease, bone damage, cancer, and neurotoxicity. Chelation therapy is used to remove cadmium from the body in cases of acute or chronic exposure.
Chelating agents bind to cadmium ions, facilitating their excretion from the body. Other drugs target specific cadmium-induced toxicities.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cadmium Ion (Cd²⁺).